Literature DB >> 15981587

Regulation of drug transporters by the farnesoid X receptor in mice.

Tomoji Maeda1, Masaaki Miyata, Takafumi Yotsumoto, Daisuke Kobayashi, Takashi Nozawa, Keisuke Toyama, Frank J Gonzalez, Yasushi Yamazoe, Ikumi Tamai.   

Abstract

The farnesoid X receptor (FXR, NR1H4) regulates bile acid and lipid homeostasis by acting as an intracellular bile acid-sensing transcription factor, resulting in altered expression of enzymes and transporters involved in bile acid synthesis and transport. Here, we quantitatively analyzed the alterations in expression levels of drug transporters, mainly organic anion-transporting polypeptides (oatp), in wild-type and FXR-null mice to evaluate the role of FXR in their expression and regulation by cholic acid. Changes in the mRNA amounts in liver, kidney, small intestine, and testis in FXR-null mice fed with or without a supplement of 0.5% cholic acid in the diet were analyzed by semiquantitative RT-PCR. In FXR-null mice, the mRNA levels of oatp1, oatp2, oatp3, and octn1 were lower than those of wild-type mice in kidney and testis, while there was no difference in liver or small intestine. Cholic acid feeding led to significantly decreased levels of expression of oatp1 and oct1 and an increased level of expression of oatp2 in wild-type mouse liver. In FXR-null mice, oatp1 and other transporters were downregulated in liver, kidney, and testis, whereas small intestine ASBT, octn2, and pept1 were upregulated. Our results suggested that FXR is involved in the transcriptional regulation of oatp and other transporters in a tissue-specific manner. Furthermore, the effect of cholic acid treatment indicates the involvement of regulatory mechanism(s) other than FXR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15981587     DOI: 10.1021/mp0499656

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  9 in total

Review 1.  FXR signaling in the enterohepatic system.

Authors:  Tsutomu Matsubara; Fei Li; Frank J Gonzalez
Journal:  Mol Cell Endocrinol       Date:  2012-05-17       Impact factor: 4.102

Review 2.  Farnesoid X receptor alpha (FXRα) is a critical actor of the development and pathologies of the male reproductive system.

Authors:  Manon Garcia; Laura Thirouard; Mélusine Monrose; Hélène Holota; Angélique De Haze; Françoise Caira; Claude Beaudoin; David H Volle
Journal:  Cell Mol Life Sci       Date:  2019-08-12       Impact factor: 9.261

Review 3.  Nuclear bile acid signaling through the farnesoid X receptor.

Authors:  Claire Mazuy; Audrey Helleboid; Bart Staels; Philippe Lefebvre
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

4.  TGF-β-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury.

Authors:  Tsutomu Matsubara; Naoki Tanaka; Misako Sato; Dong Wook Kang; Kristopher W Krausz; Kathleen C Flanders; Kazuo Ikeda; Hans Luecke; Lalage M Wakefield; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2012-10-03       Impact factor: 5.922

Review 5.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

6.  Severe diabetes and leptin resistance cause differential hepatic and renal transporter expression in mice.

Authors:  Vijay R More; Xia Wen; Paul E Thomas; Lauren M Aleksunes; Angela L Slitt
Journal:  Comp Hepatol       Date:  2012-04-23

7.  Diabetes downregulates peptide transporter 1 in the rat jejunum: possible involvement of cholate-induced FXR activation.

Authors:  Li-Min Liang; Jun-Jie Zhou; Feng Xu; Pei-Hua Liu; Lan Qin; Li Liu; Xiao-Dong Liu
Journal:  Acta Pharmacol Sin       Date:  2020-04-27       Impact factor: 7.169

Review 8.  The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders.

Authors:  Kuo-Chen Wu; Chun-Jung Lin
Journal:  J Food Drug Anal       Date:  2018-12-04       Impact factor: 6.157

9.  The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury.

Authors:  Andrea Ferrigno; Laura Giuseppina Di Pasqua; Clarissa Berardo; Veronica Siciliano; Vittoria Rizzo; Luciano Adorini; Plinio Richelmi; Mariapia Vairetti
Journal:  PLoS One       Date:  2018-01-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.